Foamix Investigational Site # 229 — Watertown, Massachusetts

Foamix Investigational Site # 229 is a clinical research site located in Watertown, Massachusetts, United States 02472.

Crixeo Clinical Trials Trust Score: 11/100 (FAILING). This profile has not yet been claimed by the site owner.

Foamix Investigational Site # 229 has participated in 2 clinical trials.

Therapeutic areas: Facial Papulopustular Rosacea, Papulopustular Rosacea.

Sponsors: Vyne Therapeutics Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Watertown

Browse all research sites in Massachusetts · View every site in Watertown

• Bay State Clinical Trials
• Adams Clinical
• MedVadis Research Corporation
• Adams Clinical Trials
• Pfizer Investigational Site
• Research Site
• Adams Clinical Watertown
• GSK Investigational Site
• Neurocrine Clinical Site
• Neumora Investigator Site
• Acusphere
• MedVadis Research

Sponsor Feasibility Report

Trust Score: 11/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Foamix Investigational Site # 229?

Foamix Investigational Site # 229 has a Crixeo Trust Score of 11/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Foamix Investigational Site # 229 conducted?

Foamix Investigational Site # 229 has 2 clinical trials on record. Their work covers Facial Papulopustular Rosacea, Papulopustular Rosacea.

Is Foamix Investigational Site # 229 accredited by Crixeo Clinical Trials?

Foamix Investigational Site # 229 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Foamix Investigational Site # 229?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.